Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis
NCT01343355Phase 3Terminated
- Sponsor
- St. Marianna University School of Medicine
- Start
- Jan 2011
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tamibarotene in HTLV-I associated myelopathy (HAM/TSP), sponsored by St. Marianna University School of Medicine. Started Jan 2011; status: terminated.
02
Drugs
tamibarotene
03
Conditions
HTLV-I associated myelopathy (HAM/TSP)
Beyond the preview
Go deeper on NCT01343355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343355.